• Publications


CYTOTHERAPY. August 2016, Volume 18, Issue 8, Pages 1043–1055. doi: 10.1016/j.jcyt.2016.05.010
Bjoern J, Iversen TZ, Nitschke JN, Andersen MH, Svane IM 
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
Elsevier Inc.

Clinical Cancer Research. January 2014. doi: 10.1158/1078-0432.CCR-13-1560
Iversen TZ , Engell-Noerregaard L, Ellebaek E, Andersen R, Stine Kiaer Larsen SK, Bjoern J, Zeyher C, Gouttefangeas C, Thomsen BM, Holm B, Straten PT, Mellemgaard A, Andersen MH, Svane IM
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase
AACR Publications

Oncoimmunology. 2016 Sep 30;5(11):e1238541. doi: 10.1080/2162402X.2016.1238541
Martinenaite E, Munir Ahmad S, Hansen M, Met Ö, Westergaard MW, Larsen SK, Klausen TW, Donia M, Svane IM, Andersen MH
CCL22 specific T Cells: Modulating the immunosuppressive tumor microenvironment
Taylor & Francis Online

Semin Immunopathol. 2016 Sep 27. [Epub ahead of print] Review. PMID: 27677755
Andersen MH
Anti-regulatory T cells 

Oncoimmunology. 2016 Jul 1;5(8):e1202391. doi: 10.1080/2162402X.2016.1202391
Munir Ahmad S, Martinenaite E, Hansen M, Junker N, Borch TH, Met Ö, Donia M, Svane IM, Andersen MH 
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

Cancer Immunol Immunother. 2016 Jan 2. [Epub ahead of print]
Ahmad SM, Borch TH, Hansen M, Andersen MH
PD-L1-specific T cells

Oncoimmunology. 2015 Aug 31;5(3):e1083672. eCollection 2016 Mar. article
Andersen MH
Novel understanding of self-reactive T cells

JNCI J Natl Cancer Inst (2015) Article
Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy